Clinical trial
Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced…
NCT00393744 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00393744 |
|---|---|
| Title | Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children |
| Official title | A Phase III, Open, Randomised, Multicentre Study Comparing the Efficacy and Safety of Pristinamycin, at Dosages of 50 mg/kg/d in 2 Doses for Children, and 1g Twice Daily in Adults for 4 Days Versus Amoxicillin at a Dosage of 50 mg/kg/d in 2 Doses in Children and 1 g Twice Daily in Adults for 6 Days… |
| Acronym | PRI-angine |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tonsillitis |
| Intervention type | Drug |
| Interventions | pristinamycin, amoxicillin |
| Enrollment | 395 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2008 |
| First posted | Oct 30, 2006 |
| Last update posted | Mar 17, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: